53 / 60
53
Acknowledgements / Satellite Symposia
Satellite Symposia
Friday, 29 May 2015
SA-01
Industry sponsored symposium
12:45 – 14:00
Lomond Auditorium
Times are changing in Adhd
An audience-expert panel discussion forum
Times are changing across the ADHD landscape and, with
the launch of new medications, so too are our ADHD
treatment choices. An international panel of experts will
discuss today’s treatment options and share their own cli-
nical practice experience on why, when and how switching
treatments may improve outcomes for appropriate child-
ren, adolescents and adults with ADHD.
International Panel:
Moderator: Hilary Jones, UK
Tim Bilkey, Canada; Matthew Brams, USA; Ana Figueroa,
Spain; Jürgen Fleischmann, Germany; Giovanni Giaroli, UK;
Matt McConkey, UK; Joel Young, USA
A Shire organised and funded symposium.
Saturday, 30 May 2015
SA-02
Industry sponsored symposium
12:45–13:45
Forth Room
SA-02-01 Introduction to symposium chairman
Johannes Thome, Germany
SA-02-02 What are the clinical features of adult
ADHD in the clinic? What do we know
beyond DSM-5?
Kobus van Rensburg, United Kingdom
SA-02-03 A focus on trajectory of response and
maintenance of response of ADHD
medications. Learnings for clinicians and
patients
Chris Bushe, United Kingdom
SA-02-04 Open debate and discussion. Implications
for future guidelines
Johannes Thome, Germany
Supported by an unrestricted educational
grant from Eli Lilly and Company.
The organizers of the 5
th
World Congress on ADHD gratefully acknowledge the support of the following companies
(as per May 2015):
Principle Sponsor
Shire
Sponsors
e
Eye Brain
e
Hayward Medical Communication
e
MEDICE Arzneimittel Pütter & Co. KG
e
neuroConn GmbH
e
Qbtech Ltd.
e
Sandoz Ltd.
e
The TOVA Company
e
Wisepress Ltd.
Non-commercial sponsor
Glasgow City Council